---
figid: PMC6397540__pnas.1821606116fig01
figlink: /pmc/articles/PMC6397540/figure/fig01/
number: F1
caption: Proposed model of cell signaling associated with the ALK5-SMAD2/3 tumor-suppressive
  arm identified by Monsivais et al. () and Kriseman et al. () in the uterus. TGF-βs
  and activins signal through TGFBR2/ALK5 and ACVR2A/ACVR2B/ALK4 receptor complexes,
  respectively. In contrast, BMPs signal through BMPR2/ACVR2A/ACVR2B and ALK1/2/3/6
  receptors, which impinge on SMAD1/5/8. Because cell signaling initiated both by
  activins and TGF-βs converges on SMAD2/3, ALK4 and ALK5 may play redundant roles
  in endometrial cancer development. The existence of antagonisms between tumor-suppressive
  TGF-β and oncogenic BMP signaling is supported by increased expression of BMP target
  genes in Smad2/3 cKO uteri (). It should be pointed out that the ligand-induced
  cell signaling, receptor utilization, and pathway interactions shown in this model
  require further experimental testing.
pmcid: PMC6397540
papertitle: Tumor-suppressive signaling in the uterus.
reftext: Qinglei Li. Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3367-3369.
pmc_ranked_result_index: '16149'
pathway_score: 0.9141817
filename: pnas.1821606116fig01.jpg
figtitle: Proposed model of cell signaling associated with the ALK5-SMAD2/3 tumor-suppressive
  arm identified by Monsivais et al
year: '2019'
organisms: Homo sapiens
ndex: 354849e7-dedd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6397540__pnas.1821606116fig01.html
  '@type': Dataset
  description: Proposed model of cell signaling associated with the ALK5-SMAD2/3 tumor-suppressive
    arm identified by Monsivais et al. () and Kriseman et al. () in the uterus. TGF-βs
    and activins signal through TGFBR2/ALK5 and ACVR2A/ACVR2B/ALK4 receptor complexes,
    respectively. In contrast, BMPs signal through BMPR2/ACVR2A/ACVR2B and ALK1/2/3/6
    receptors, which impinge on SMAD1/5/8. Because cell signaling initiated both by
    activins and TGF-βs converges on SMAD2/3, ALK4 and ALK5 may play redundant roles
    in endometrial cancer development. The existence of antagonisms between tumor-suppressive
    TGF-β and oncogenic BMP signaling is supported by increased expression of BMP
    target genes in Smad2/3 cKO uteri (). It should be pointed out that the ligand-induced
    cell signaling, receptor utilization, and pathway interactions shown in this model
    require further experimental testing.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFBR1
  - BMPR1B
  - BMPR1A
  - ACVR1B
  - TGFB2
  - ACVR1
  - ACVR2A
  - ACVR2B
  - GDF7
  - TGFBR2
  - BMP7
  - GDF6
  - SMAD1
  - SMAD2
  - BMP2
  - SMAD7
  - BMP4
  - BMP5
  - BMP6
  - BMP3
  - BMP8B
  - GDF5
  - GDF1
  - SMAD6
  - BMPR2
  - SMAD3
  - INHBA
  - INHBB
  - SMAD9
  - SMAD4
  - GDF3
  - SMAD5
  - BMP15
  - BMP1
  - BMP10
  - BMP8A
  - TGFB1
  - TGFB3
  - GDF2
  - SMAD -------->
genes:
- word: ALK5
  symbol: ALK-5
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: ALK1/2/3/6
  symbol: ALK6
  source: hgnc_alias_symbol
  hgnc_symbol: BMPR1B
  entrez: '658'
- word: ALK1/2/3/6
  symbol: ALK3
  source: hgnc_alias_symbol
  hgnc_symbol: BMPR1A
  entrez: '657'
- word: ALK4
  symbol: ALK4
  source: hgnc_alias_symbol
  hgnc_symbol: ACVR1B
  entrez: '91'
- word: TGFB/ActivinSignaling
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: ALK1/2/3/6
  symbol: ALK2
  source: hgnc_alias_symbol
  hgnc_symbol: ACVR1
  entrez: '90'
- word: ACVR2A
  symbol: ACVR2A
  source: hgnc_symbol
  hgnc_symbol: ACVR2A
  entrez: '92'
- word: ACVR2B
  symbol: ACVR2B
  source: hgnc_symbol
  hgnc_symbol: ACVR2B
  entrez: '93'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF7
  entrez: '151449'
- word: TGFBR2
  symbol: TGFBR2
  source: hgnc_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP7
  entrez: '655'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF6
  entrez: '392255'
- word: SMAD--------→
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: SMAD--------→
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP2
  entrez: '650'
- word: SMAD--------→
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP4
  entrez: '652'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP5
  entrez: '653'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP6
  entrez: '654'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP3
  entrez: '651'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP8B
  entrez: '656'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF5
  entrez: '8200'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF1
  entrez: '2657'
- word: SMAD--------→
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: BMPR2
  symbol: BMPR2
  source: hgnc_symbol
  hgnc_symbol: BMPR2
  entrez: '659'
- word: SMAD2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: TGFB/Activin
  symbol: Activin
  source: bioentities_symbol
  hgnc_symbol: INHBA
  entrez: '3624'
- word: TGFB/Activin
  symbol: Activin
  source: bioentities_symbol
  hgnc_symbol: INHBB
  entrez: '3625'
- word: SMAD--------→
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD--------→
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: SMAD--------→
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF3
  entrez: '9573'
- word: SMAD--------→
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: SMAD1/5/8
  symbol: SMAD5
  source: hgnc_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP15
  entrez: '9210'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP1
  entrez: '649'
- word: SMAD1/5/8
  symbol: SMAD1
  source: hgnc_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP10
  entrez: '27302'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: BMP8A
  entrez: '353500'
- word: TGFB/ActivinSignaling
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB/ActivinSignaling
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: BMP
  symbol: BMP
  source: bioentities_symbol
  hgnc_symbol: GDF2
  entrez: '2658'
- word: SMAD1/5/8
  symbol: SMAD8
  source: hgnc_alias_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
chemicals:
- word: SMAD -------->
  source: ''
  identifier: ''
diseases: []
figid_alias: PMC6397540__F1
redirect_from: /figures/PMC6397540__F1
figtype: Figure
---
